Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

VC Roundup: 2016 US Investment Ends On A Down Note, But Biopharma Has Second-Best Year

Jan 31 2017

• By Mandy Jackson

VC Roundup

Related Content

VC Roundup: 2Q Financings Fall As Per-Company Averages Rise

Jul 20 2016

US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Dec 31 2016

VC Roundup: Flagship’s New Fund Designed To Raise Its Stake In Startups

Dec 23 2016

VC Roundup: Cleave Raises $37m To Maintain Phase I Momentum, Plus $233.5m In Recent Financings

Aug 10 2016

VC Roundup: Infectious Disease Startup Snags $150m And Former Biogen CEO Scangos

Jan 08 2017

Early Stage Biopharma Financings Kept Up Multibillion-Dollar Pace In 2016

Jan 05 2017

VC Roundup: October Brings Several New Venture Funds, Including Third Rock’s Fourth

Nov 01 2016

Led By Former Kythera Executives, Unity Raises $116m To Make Aging Less Painful

Nov 02 2016

Related Companies

Helsinn Healthcare SA

UNITY Biotechnology, Inc.

Synthorx, Inc.

Vir Biotechnology, Inc.

Adynxx, Inc.

OncoImmune, Inc.

Johnson & Johnson

Chroma Therapeutics Limited

Eternygen GmbH

Fibrocor Therapeutics L.P.

Additional Topics

Financing StartUps and SMEs Companies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window